Yahoo Web Search

  1. Ads

    related to: memorial sloan-kettering cancer center

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 1 day ago

      Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt, M.D., of Memorial Sloan Kettering

  1. Ad

    related to: memorial sloan-kettering cancer center